Выбор темы
Выбор стиля шрифта
Sanofi новости
27/12
Отчет иностранного эмитента (6-K) - Sanofi
24/07
Отчет иностранного эмитента (6-K) - Sanofi
21/01
🔗
Zacks Investment Research: Sanofi (SNY) 2nd Dupixent Prurigo Nodularis Study Meets Goal (Revised)
20/01
🔗
Zacks Investment Research: Sanofi (SNY) 2nd Dupixent Prurigo Nodularis Study Meets Goal
12/01
🔗
Seeking Alpha: Sanofi (SNY) CEO Paul Hudson Presents at JPMorgan 40th Annual Healthcare Conference (Transcript)
11/01
🔗
GuruFocus: Shares of Sanofi, Exscientia Rise on News of Collaboration
10/01
🔗
Zacks Investment Research: Sanofi (SNY) Inks Deal to Develop AI-Driven Precision Medicines
07/01
🔗
Stockmarketcom: Which Stocks To Buy Now? 4 Biotech Stocks To Know
04/01
🔗
Benzinga: Sanofi Expects Q4 FY21 Vaccine Sales Lower Than Year-Ago, Positive Currency Impact
21/12
🔗
Zacks Investment Research: Sanofi (SNY) to Acquire Amunix, Boost Immuno-oncology Pipeline
21/12
🔗
Reuters: Sanofi in $1 billion deal to buy U.S.-based Amunix Pharma
15/12
🔗
Forbes: Sanofi, GSK Say Covid Vaccine Works As Booster Shot
15/12
🔗
Proactive Investors: GlaxoSmithKline/Sanofi Covid-19 vaccine effective as booster shot, trial shows
14/12
🔗
Benzinga: Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
13/12
🔗
Zacks Investment Research: Sanofi (SNY) Multiple Myeloma Phase III Study Meets Goal
08/12
🔗
Zacks Investment Research: Sanofi's (SNY) Filing for Rare Disease Drug Accepted by EMA
07/12
🔗
Seeking Alpha: Buy Sanofi After The Dip
01/12
🔗
Benzinga: Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition
10/11
Отчет иностранного эмитента (6-K) - Sanofi
08/10
МНЕНИЕ: Sanofi - образец адаптивности в условиях пандемии - Финам
Загрузить еще